The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Fateeva V.V.

Sechenov First Мoscow State Medical University, Moscow, Russia

Shumacher G.I.

Altai State Medical University, Barnaul

Vorobyova E.N.

Barnaul Multidisciplinary Medical Center «Isida», Barnaul, Russia

Horeva M.A.

Altai State Medical University, Barnaul, Russia

Voskanyan L.R.

Altai State Medical University, Barnaul, Russia

Tthe efficacy and safety of drug therapy divaza in patients with chronic cerebral ischemia

Authors:

Fateeva V.V., Shumacher G.I., Vorobyova E.N., Horeva M.A., Voskanyan L.R.

More about the authors

Read: 3773 times


To cite this article:

Fateeva VV, Shumacher GI, Vorobyova EN, Horeva MA, Voskanyan LR. Tthe efficacy and safety of drug therapy divaza in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):32‑37. (In Russ.)
https://doi.org/10.17116/jnevro20171172132-37

Recommended articles:
Headache and cognitive impairment in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):78-81

References:

  1. Skvortsova V.I. Snizhenie morbidity, mortality and disability from stroke in the Russian Federation. 2008;194. (In Russ.).
  2. Damulin IV, Parfenov VA, Skoromets AA NN Yahno. Disorders of blood circulation in the brain and spinal cord. In the book: «Diseases of the nervous system. Guidelines for doctors». Eds. Yahno NN, Shtulman DR. M.: Meditsina; 2005. (In Russ.).
  3. Skvortsova VI, Evzelman MA Ischemic stroke. Orel. 2006;404. (In Russ.).
  4. Gusev EI, Martynov MYu, Yasamanova AN, Kolesnikova TI, Kabanov AA, Petukhov EB, Berezov VP. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2001;1:41-45. (In Russ.).
  5. Kadykov AS, Manvel LS, Shahparonova NV. Chronic vascular diseases of the brain: encephalopathy: a guide for physicians. 3-e izd., pererab. i dop. M.: GEOTAR-Media; 2014. (In Russ.).
  6. Afanasiev VV, Rumyantsev SA, Silin EV. Pathophysiology and Therapy tektivnaya neyropro-ischemic brain damage. Meditsinskii Sovet. 2008;9-10:35-39. (In Russ.).
  7. Oganov RG. The concept of risk factors as a basis for the prevention of cardiovascular diseases. Vrach. 2001;7:3-7. (In Russ.).
  8. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: A Guideline from the American Heart Association/American Stroke Association Stroke Council : Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633. doi:10.1161/01.str.0000223048.70103.f1
  9. Gusev EI, Chukanova AS. Modern pathogenetic aspects of the formation of chronic brain ischemia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;3:4-8. (In Russ.).
  10. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, Age, Cardiovascular Risk Factors, and coronary heart disease: A Prospective Follow-Up Study of 14786 Middle-Aged Men and Women in Finland. Circulation. 1999;99:9:1465-1472. doi:10.1161/01.cir.99.9.1165
  11. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109:27-33. doi:10.1161/01.CIR.0000129501.88485.1f
  12. Viktorov IV. The role of nitric oxide and other free radicals in cerebral ischemic pathology. Vestnik RAMN. 2004;4:5-10. (In Russ.).
  13. Malyshev IY, Collegiate EA, Smirin BV, Manukhina EB. Hypoxia and nitric oxide. Vestnik RAMN. 2000;9:44-48. (In Russ.).
  14. Gorbachev VI, Kovalev VV. The role of nitric oxide in the pathogenesis of lesions of the central nervous system dameges. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Prilozhenie «Insul't»). 2002;7:9-16. (In Russ.).
  15. Forstermann U, Biossel J-P, Kleinert H. Expressional control of the «constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12:773-790.
  16. Manukhina EB, Malyshev IYu, Smirin BV, Mashina SYu, Saltykova VA, Vanin AF. Production and storage of nitric oxide in adaptation to hypoxia. Nitric Oxide. 1999;3:393-401. doi:10.1006/niox.1999.0244
  17. Neubauer JA. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol. 2001;90:1593-1599. doi:10.1016/j.resp.2008.10.012
  18. Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000;90:244-254. doi:10.1111/j.1476-5381.2010.01196.x
  19. Nechipurenko NI, Pashkovskaya ID, Musienko YuI. Basic pathophysiological mechanisms of cerebral ischemia. Meditsinskie novosti. 2008;1:7-13. (In Russ.).
  20. Hladovec J. Circulating endothelial cells as sign of vessel wall lesions. Physiol Bohemoslov. 1978;27(2):140-144.
  21. Trailin AV, Levada OA Protein S100B: neuroscience, the value in neurological and psychiatric pathology. Mezhdunarodnyi nevrologicheskii zhurnal. 2009;3:1(23):166-172. (In Russ).
  22. Nishiyama H, Knopfel T, Endo S, Itohara S. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad Sci USA. 2002;99:4037-4042. doi:10.1073/pnas.052020999
  23. Selinfreud RH, Barger SW, Pledger WJ, Van Eldik LJ. Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci USA. 1991;88:3554-2558. doi:10.1073/pnas.88.9.3554
  24. Van Eldik LJ, Christie-Pope B, Bolin LM, Shooter EM, Whetsell WO. Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 1991;542:280-285. doi:10.1016/0006-8993(91)91579-p
  25. Reeves RH, Yao J, Crowley MR, Buck S, Zhang X, Yarowsky P, Gearhart JD, Hilt DC. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc Natl Acad Sci USA. 1994;91:5359-5363. doi:10.1073/pnas.91.12.5359
  26. Brewton LS, Haddad L, Azmitia EC. Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures israpidly reversed by applied S-100β. Brain Res. 2001;912:9-16. doi:10.1016/j.bbamcr.2007.01.003
  27. Kamchatnov PR, Vorobyov OV, Rachin AP. Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;4:52-56. (In Russ.).
  28. Abdurasulova IN, Mukhin VN, Klimenko VM, Zhavbert ES, Dugina YuL. Comparative study of the efficacy tenoten, Impaza and Divazy model of beta-amyloid amnesia in rats. Materialy XXI Rossiiskogo natsional'nogo kongressa «Chelovek i lekarstvo». M. 2014;191. (In Russ.).
  29. Denisova TD, Salikova LR, Lebedeva SA, Tekutova TV, Bugaeva LI, Petrov VI, Gur'yanova NN, Dugina YuL. Effect of tenoten Divazy and the duration of hexenal sleep male rats in chronic Materials Science Experiment. Materialy XXI Rossiiskogo natsional'nogo kongressa «Chelovek i lekarstvo». M. 2014;234. (In Russ.).
  30. Zhavbert KH, Guryanov NN, Surkov EI, Dugina YuL, Kachaeva EV, Epshtein OI, Myshkin VA, Gurto RV. A study on the impact of Divazy lipid peroxidation. Proceedings of the XXI Russian National Congress «Man and medicine». M. 2014;242. (In Russ.).
  31. Heifetz IA, Voronina TA, Molodavkin GM, Dugina YuL. Experimental study of anxiolytic antidepressant drug action Divaza. Materialy VIII mezhdunarodnogo mezhdistsiplinarnogo kongressa «Neironauka dlya meditsiny i psikhologii». Sudak. 2012. (In Russ.).
  32. Schmidt EV. Classification of vascular brain and spinal cord injuries. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1985;9:1281-1288. (In Russ.).
  33. Zakharov VV. Neuropsychological tests. The need and opportunity to use. Consilium medicum. 2011;13:2:82-90. (In Russ.).
  34. Zakharov VV, Yahno NN. Cognitive disorders in elderly and senile age. M. 2005. (In Russ.).
  35. Manukhina EB, Malyshev IYu. The role of nitric oxide in the development and prevention of endothelial dysfunction. Vestnik VGMU. 2003;2:2:5-18. (In Russ.).
  36. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL. AHA/ASA Scientific Statement Definition and Evaluation of Transient Ischemic Attack. Stroke. 2009;40:2276-2293.
  37. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovascular Diseases. 2008;25:457-507. doi:10.1159/000131083

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.